IFF has entered into an agreement to acquire Health Wright Products, LLC (HWP), a leader in formulation and capsule manufacturing for the dietary supplement industry that generated about $100 million in annual revenue in 2021. Founded in 1995, HWP is located in Clackamas, OR and is a privately-owned and long-time business partner of IFF’s Health & Biosciences probiotics business.

HWP manufactures custom formulations and delivers encapsulation and packaging to meet the industries’ requirements for probiotic products. The company maintains 165,000 square feet of manufacturing space and employs more than 225 people who will continue with the company after the sale, according to IFF.

The acquisition will bring formulation and finished format capabilities to IFF’s Health & Biosciences probiotics, natural extracts and botanicals businesses, allowing for innovation in custom formulation and combination products.

“Today’s announcement is driven by our commitment to enhance long-term value to our partners and customers,” said Simon Herriott, president, IFF’s Health & Biosciences division. “Producing thousands of unique and complex formulations for the industry’s most trusted brands, Health Wright Products formulation and finished format abilities will allow us to develop new and customized solutions and formats for a broad base of customers”

“We look forward to joining IFF’s Health & Biosciences division,” said HWP President Mark Wright. “Health Wright Products best-in-class quality manufacturing and formulation capabilities, combined with the strong biotech innovation pipeline of IFF’s Health & Biosciences, is an exciting proposition for our customers and employees.”

The sale is expected to close in the first quarter of 2022, subject to customary closing conditions. Financial terms were not disclosed.